michaeltmccarthy (@mccarthymt7) 's Twitter Profile
michaeltmccarthy

@mccarthymt7

reduce turbulence, increase flow

ID: 1571824613029548033

linkhttps://www.linkedin.com/in/michael-mccarthy-06144683 calendar_today19-09-2022 11:32:55

1,1K Tweet

1,1K Followers

311 Following

michaeltmccarthy (@mccarthymt7) 's Twitter Profile Photo
michaeltmccarthy
@mccarthymt7

2 months ago

I was disappointed to learn this morning that the combination of pembrolizumab and lenvatinib for patients with advanced endometrial cancer (nejm.org/doi/pdf/10.105…) has been turned down for reimbursement by the HSE. Until now, there has been an expanded access programme, and I

I was disappointed to learn this morning that the combination of pembrolizumab and lenvatinib for patients with advanced endometrial cancer (nejm.org/doi/pdf/10.105…) has been turned down for reimbursement by the HSE. Until now, there has been an expanded access programme, and I